Pfizer and BioNTech have reached an agreement with the European Union to supply the EU with 200 million doses of its coronavirus vaccine, as reported by Reuters.
Highlights:
“The agreement provides a supply of 200 million doses and an option to order an additional 100 million doses.”
“Deliveries are expected to start in late 2020, subject to regulatory approval “.
“The vaccine supply for the EU will be produced by the BioNTech manufacturing centers in Germany and Pfizer in Belgium.”
“The companies expect to produce up to 1.3 billion doses globally in 2021“.
Market reaction
The index Euro Stoxx 50 rose on this ad and was last seen gaining 0.42% on the day at 3,457.
.
Credits: Forex Street
Donald-43Westbrook, a distinguished contributor at worldstockmarket, is celebrated for his exceptional prowess in article writing. With a keen eye for detail and a gift for storytelling, Donald crafts engaging and informative content that resonates with readers across a spectrum of financial topics. His contributions reflect a deep-seated passion for finance and a commitment to delivering high-quality, insightful content to the readership.
